INTRODUCTION
Use of plants started with the start of human civilization, not only for food purpose, but also for healing. The plant materials initially took the form of crude drugs such as poultices, powders, tinctures, and many other herbal formulations [1] . According to WHO, almost 80% of the world's populations depends upon natural products for their health [2] . Glycation is involved in several diabetes-associated complications like retinopathy, neuropathy, and nephropathy. The accumulation of glycation end products along with proteins compromises their physiological functions [3] . The formation of advanced glycation end-products (AGEs) progressively increases with normal aging and is accelerated in diabetes [4] . Organic material of plant origin with significant antiglycation activity can be used for prevention of diabetic complications. Large amounts of reactive oxygen species (ROS) are produced by neutrophils and monocytes in response to infection which kill microorganisms. Excessive ROS concentration is toxic to host cells that causes tissue damage and numerous inflammatory reactions. Plants that contain immunomodulatory constituents may be used to reduce such inflammatory responses [5] . Urease catalysis the hydrolysis of urea to form ammonia and carbon dioxide; and therefore ureaseinhibitory activity has been designed to quantify the end products produced during this reaction. The advantageous objective of urease inhibition is to reduce the concentration of carbon dioxide and ammonia and ultimately reduction in ulcer. Carbonic anhydrase inhibition is also correlated with anti-ulcerative activity.
Many plants of genus Ruellia have been used as diuretic, anti-diabetic, anti-pyretic, analgesic, anti-oxidant, anti-hypertensive and gastroprotective [6, 7] . Phytochemical constituents which have a wide range of biological activities such as glycoside, alkaloids, flavonoids, triterpenoids have been reported from genus Ruellia [8, 9] . Ruellia squarrosa has recently been evaluated for its anticancer activity [10] .
This study was designed to evaluate the immunomodulatory, antiglycation and antiulcerative enzyme inhibition activities of dichloromethane and methanol extracts of aerial parts and roots of Ruellia squarrosa.
EXPERIMENTAL
Ruellia squarrosa was collected from the area near to Bahauddin Zakariya University, Multan. Dr. Altaf Ahmed Dasti, from the Institute of Pure and Applied Biology, B.Z.U, Multan identified the plant. The plant parts were deposited in the department's herbarium with the specimen's No FL.C. 1-2 for future reference. The shaded and dried plant material (roots and aerial parts) of Ruellia squarrosa was ground and macerated with dichloromethane and methanol for three days. Both dichloromethane and methanol extracts were concentrated by using the Rota Vapor. The four extracts used in this study were: RSAD (Ruellia squarrosa-Aerial partsDichloromethane extract); RSAM (Ruellia squarrosa-Aerial parts-Methanol extract); RSRD (Ruellia squarrosa-Roots-Dichloromethane extract); and RSRM (Ruellia squarrosa-RootsMethanol extract).
Immunomodulatory activity
We estimated the immunomodulatory activity of the extracts by using Luminol-enhanced chemiluminescence assay. Fresh blood was taken from healthy human volunteers. 25 µL of whole blood and 25 µL of the sample in Hank's balanced slat solution (containing MgCl 2 and CaCl 2 ) were placed in an incubator. Then the mixture was dissolved in MeOH (3.1-100 µg/mL) and added 25 µL of zymosan, followed by chemiluminescence probe luminol (25 µL). Then HBSS++ was added to adjust the final volume to 0.1 ml. The chemiluminescence's peaks were recorded with a Lumino meter (Luminoskan, Finland) [11] .
Antiglycation assay
Bovine serum albumin (BSA) solution was prepared in 20 µL, 100 mM phosphate buffer with 20 µL, 3 mM solution of sodium azide. The same concentration was used to prepare glucose solution (800 mM). 20 µL, 500 mM of dimethyl sulfoxide, 50 µL of BSA, 50 µL of glucose, 80µL of phosphate buffer were mixed in the well and in the reaction mixture was placed in the incubators at 37 ⁰C for one week. The sample analysis was performed by using spectrophotometer at 440 nm wavelength. [12] . Percentage inhibition of AGEs (advanced glycation end-products) formation was calculated by using Eq 1.
Anti-ulcerative enzyme inhibition activities i) Urease inhibition assay: Reaction mixtures comprising 25μL of enzyme solution and 55 μL of buffers were placed in an incubator with 5 μL of the extract for 15-20 minutes in 96-well plates. Urease inhibition activity was determined by the indophenol method by using spectrophotometer and taking absorbance at 625 nm. Thiourea was used as the standard inhibitor of urease [13] .
Percentage inhibition was measured by using formula given in Eq 2.
% Inhibition = 100-(OD testwell /OD control ) ×100 .. (2) ii) Carbonic anhydrase inhibition activity: Carbonic anhydrase inhibition assay was performed according to Ashiq et al with slight modification. The total mixture volume was 200 µL in a well containing 140 μL (20 Mm HEPES (Bioworld: Cat# 40820000-1) tris buffer (Invitrogen: Cat# 15504-020, pH 7.4), 20 μL of the enzyme (Sigma Aldrich, C2624, PCode: 1001584424) (0.1 -0.2 mg ̸ mL in deionized water); 20 μL (0.5 mg ̸ mL in DMSO) of test compound was mixed and incubated at 25 o C for 15 min. After incubation pre-read was taken at 400 nm and 20 μL of substrate (4-nitrophenol acetate, Sigma Aldrich, N8130, lot#BCBK4587V) (0.7 mM in methanol) was added and reincubated at the same condition for 30 min and after read was taken at 400 nm. Acetazolamide was taken as positive control. IC 50 was calculated by making serial dilution of original concentration [14] . Inhibition (H) was calculated as given in Eq 3.
H (%) = 100-(A t /A c )100 ………………… (3)

Statistical analysis
Data collected were analysed using descriptive statistics. Comparison of means was achieved using one way ANOVA. At 95% confidence interval, 2-tailed p values less than 0.05 were considered significant.
RESULTS
The dichloromethane extract of aerial parts of the plant showed immunomodulatory activity with IC 50 39.48 ± 8.06 using ibuprofen as standard ( Table 1 ).
The dichloromethane extract of the aerial parts of the plant showed antiglycation activity (IC 50 382.21±3.43) as compared to standard, rutin (IC 50 121.68±1.04); while the other extracts of the plant showed no activity ( Table 2 ).
The methanol extract of the aerial parts of the plant showed urease inhibition activity with IC 50 130.2±0.57 using thiourea as standard ( Table 3 ).
The methanol extract of the aerial parts of the plant showed carbonic anhydrase inhibition activity with IC 50 1656.7 ± 0.08 using acetazolamide as standard (Table 4) . 
DISCUSSION
Immunomodulators are chemicals that upregulate or down-regulate the immune system. Immunomodulators have been accepted as very useful drugs because of their wide functions [15] . Various disease conditions such as infections, organ transplant rejection, cancer, rheumatoid arthritis, and systemic lupus erythematosus are currently treated with immunomodulating agents [16] . Many plants with immunomodulatory activities have been reported e.g. Thamnolia vermicularis [17] . In this study, aerial parts of the methanol extract of R. squarrosa showed a very good immunomodulatory activity, five times greater than the standard.
Glycation is a condensation reaction between sugars and amino groups of proteins and form advanced glycation products (AGPs). This reaction depends on half-life of the proteins and permeability to free glucose [18, 19] . AGEs play a useful role in diabetic care where it deposits under endothelial cells and actually causing the decrease in blood sugar concentration. Glycoxidation causes protein dysfunction suggesting the pathological factor involved in diabetes [20, 21] . In the present study, dichloromethane extract of aerial parts of R. squarrosa showed comparable results with the standard.
Urease and carbonic anhydrase inhibition are correlated with anti-ulcerative activity. Our extracts showed very good anti-ulcerative activity.
CONCLUSION
The findings of this study demonstrate that Ruellia squarrosa possesses immunomodulatory activity and therefore have anti-angiogenic properties and thus, may be suitable for the treatment of cancer. Its antiglycation and antiulcerative properties indicate that they could find use in the treatment of diabetes and gastric ulcer, respectively. However, further studies are required to ascertain its clinical potentials.
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